AI tool predicts liver cancer relapse with 82% accuracy, tackling a disease causing third-highest cancer-related deaths ...

Nkarta's pipeline updates show steady progress, but no major catalysts have emerged. Read what warrants a cautious outlook on ...

The six-year study focused on cyproheptadine, the active compound in the antihistamine Periactin. Periactin is commonly ...

Troculeucel, a cryopreserved, autologous enhanced natural killer cell therapy, has demonstrated preliminary clinical benefit without any drug-related adverse events in two Phase I clinical trials in ...

In connection with HekaBio’s recently announced strategic investment in NKGen, the partnership will expedite the regulatory, manufacturing, and commercial development of NKGen’s autologous NK cell ...

Immod Innovations, a leader in specialty nutrition, is proud to announce that its flagship supplement, CellBB (Cell Boost and Balance), has been spotlighted in a feature article by Wellness Magazine ...

Funding in the amount of $2.0M from Japanese strategic investor, in the form of common equity PIPE with warrants. New funding provides for necessary resources to regain compliance with reporting oblig ...

Funding in the amount of $2.0M from Japanese strategic investor, in the form of common equity PIPE with warrants. New funding provides for necessary resources to regain compliance with reporting ...

Mesenchymal stem cell therapy lessens disability and brain lesions in MS patients, according to a review of published studies ...